NEFL and Alzheimer disease: In this regard, a growing number of evidence suggests that MBI is associated with alterations in structural and functional neuroimaging studies, higher neurofilament light chain levels that are indicative of axonal damage, higher genetic predisposition to clinical diagnosis of AD, as well as AD-related biomarkers assessed in the blood, CSF, and PET.